Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Dallas, TX, United States. The current CEO is Donal R. Schmidt Jr..
RTSL has IPO date of 2017-06-14, 3 full-time employees, listed on the Other OTC, a market capitalization of $52.99K.
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.
